VA
AMN icon

Verdad Advisers’s AMN Healthcare AMN Stock Holding History

Verdad Advisers’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
51,906
+1,906
+4% +$49.2K 1.61% 9
2026
Q1 		$917K Buy
50,000
+5,000
+11% +$95.1K 1.03% 27
2025
Q4 		$709K Buy
+45,000
New +$803K 0.81% 46

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Verdad Advisers's AMN Position: Q2 2026 in Review

Verdad Advisers increased its AMN Healthcare (AMN) stake by 3.8% in Q2 2026, buying an estimated $49.2K and bringing the position to 51,906 shares worth $1.68M. The position accounts for 1.61% of the portfolio, ranked #9.

Verdad Advisers first reported a position in AMN in Q4 2025 and has held it in 3 quarters since. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Verdad Advisers held 51,906 shares of AMN Healthcare worth $1.68M as of Q2 2026.
  • Verdad Advisers bought 1,906 AMN Healthcare shares in Q2 2026, an estimated $49.2K.
  • AMN Healthcare made up 1.61% of Verdad Advisers's portfolio in Q2 2026, its #9 holding.
  • Verdad Advisers first reported a position in AMN Healthcare in Q4 2025 and has held it in 3 quarters since.
  • 285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.